only one respondent offered any insight into this situation observing that the main barrier to promoting genomics for infectious disease control in luxembourg is the fact that responsibility for controlling infectious disease in the grand duchy rests exclusively with the laboratoire national de sante it would appear that in this instance at least institutional separation of infectious disease control from other elements of the healthcare and biomedical research system may seriously impede innovation in this area two respondents suggested that international collaboration might help to overcome such barriers but offered no specific recommendations for how to achieve this these include the national institute of genomic medicine established in where highthroughput technology has been adopted to support research ongoing in laboratories around the country as well as programmes supported by the foundation carlos slim for health and the mexican association of medical schools